ATTENTION Insulet Corporation (PODD) Investors: Possible Fraud - Contact Levi & Korsinsky TodayNewsfile Corp • 03/30/26
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law FirmBusiness Wire • 03/28/26
PODD Investor Alert: Insulet Corp. Potential Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Misled on Safety: Levi & KorsinskyGlobeNewsWire • 03/26/26
PODD ACTIVE INVESTIGATION: Lost Money on Insulet Corporation? Contact Levi & Korsinsky NowNewsfile Corp • 03/23/26
Insulet (PODD) Down 8.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/20/26
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire • 03/19/26
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 03/18/26
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationBusiness Wire • 03/18/26
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBusiness Wire • 03/13/26
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire • 03/13/26
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.Business Wire • 03/12/26
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 DiabetesBusiness Wire • 03/11/26
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)Business Wire • 03/10/26
Insulet (PODD) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/18/26
Exploring Analyst Estimates for Insulet (PODD) Q4 Earnings, Beyond Revenue and EPSZacks Investment Research • 02/12/26